These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31007741)

  • 1. Silenced PITX1 promotes chemotherapeutic resistance to 5-fluorocytosine and cisplatin in gastric cancer cells.
    Shen X; Gu Y; Yu S; Gong P; Mao Y; Li Y; Zheng Y; Qiao F; Zhao Z; Fan H
    Exp Ther Med; 2019 May; 17(5):4046-4054. PubMed ID: 31007741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-675 is frequently overexpressed in gastric cancer and enhances cell proliferation and invasion via targeting a potent anti-tumor gene PITX1.
    Liu L; Tian YC; Mao G; Zhang YG; Han L
    Cell Signal; 2019 Oct; 62():109352. PubMed ID: 31260797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5.
    Qiao F; Gong P; Song Y; Shen X; Su X; Li Y; Wu H; Zhao Z; Fan H
    Cell Physiol Biochem; 2018; 46(6):2215-2231. PubMed ID: 29734189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of pituitary homeobox 1 gene in human gastric carcinogenesis and its clinicopathological significance.
    Chen YN; Chen H; Xu Y; Zhang X; Luo Y
    World J Gastroenterol; 2008 Jan; 14(2):292-7. PubMed ID: 18186570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
    Zhou J; Chen Q
    FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro effect of a combination of 5-fluorouracil (5-FU) and cisplatin (CDDP) on human gastric cancer cell lines: timing of cisplatin treatment.
    Cho H; Imada T; Oshima T; Shiozawa M; Rino Y; Takanashi Y
    Gastric Cancer; 2002; 5(1):43-6. PubMed ID: 12021859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression.
    Huang X; Li Z; Zhang Q; Wang W; Li B; Wang L; Xu Z; Zeng A; Zhang X; Zhang X; He Z; Li Q; Sun G; Wang S; Li Q; Wang L; Zhang L; Xu H; Xu Z
    Mol Cancer; 2019 Mar; 18(1):71. PubMed ID: 30927924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines.
    Mora-Lagos B; Cartas-Espinel I; Riquelme I; Parker AC; Piccolo SR; Viscarra T; Reyes ME; Zanella L; Buchegger K; Ili C; Brebi P
    PLoS One; 2020; 15(1):e0228331. PubMed ID: 31990955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.
    Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
    Oncol Rep; 2005 Sep; 14(3):609-15. PubMed ID: 16077963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAB13 as a novel prognosis marker promotes proliferation and chemotherapeutic resistance in gastric cancer.
    Chen P; Chen G; Wang C; Mao C
    Biochem Biophys Res Commun; 2019 Oct; 519(1):113-120. PubMed ID: 31474334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Less cytotoxicity to combination therapy of 5-fluorouracil and cisplatin than 5-fluorouracil alone in human colon cancer cell lines.
    Chen XX; Lai MD; Zhang YL; Huang Q
    World J Gastroenterol; 2002 Oct; 8(5):841-6. PubMed ID: 12378627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-195 reverses 5-FU resistance through targeting HMGA1 in gastric cancer cells.
    Wang CQ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3771-3778. PubMed ID: 31115003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-30 decreases multidrug resistance in human gastric cancer cells by modulating cell autophagy.
    Du X; Liu B; Luan X; Cui Q; Li L
    Exp Ther Med; 2018 Jan; 15(1):599-605. PubMed ID: 29375703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aquaporin 3 facilitates chemoresistance in gastric cancer cells to cisplatin
    Dong X; Wang Y; Zhou Y; Wen J; Wang S; Shen L
    Cell Death Discov; 2016; 2():16087. PubMed ID: 27867537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EZH2 contributes to 5-FU resistance in gastric cancer by epigenetically suppressing FBXO32 expression.
    Wang C; Li X; Zhang J; Ge Z; Chen H; Hu J
    Onco Targets Ther; 2018; 11():7853-7864. PubMed ID: 30464532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
    Kim R; Tanabe K; Inoue H; Toge T
    Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose cisplatin and 5-fluorouracil in combination can repress increased gene expression of cellular resistance determinants to themselves.
    Nishiyama M; Yamamoto W; Park JS; Okamoto R; Hanaoka H; Takano H; Saito N; Matsukawa M; Shirasaka T; Kurihara M
    Clin Cancer Res; 1999 Sep; 5(9):2620-8. PubMed ID: 10499641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose all-trans retinoic acid enhances cytotoxicity of cisplatin and 5-fluorouracil on CD44(+) cancer stem cells.
    Najafzadeh N; Mazani M; Abbasi A; Farassati F; Amani M
    Biomed Pharmacother; 2015 Aug; 74():243-51. PubMed ID: 26349992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MACC1 mediates chemotherapy sensitivity of 5-FU and cisplatin via regulating MCT1 expression in gastric cancer.
    Wang C; Wen Z; Xie J; Zhao Y; Zhao L; Zhang S; Liu Y; Xue Y; Shi M
    Biochem Biophys Res Commun; 2017 Apr; 485(3):665-671. PubMed ID: 28235486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of NLRC5 attenuates the malignant growth and enhances the sensitivity of gastric cancer cells to 5-FU chemotherapy by blocking the carcinogenic effect of YY1.
    Liang S; Xiang T; Liu S; Xiang W
    Exp Ther Med; 2022 Sep; 24(3):601. PubMed ID: 35949331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.